2004
DOI: 10.1016/j.jchemneu.2004.02.003
|View full text |Cite
|
Sign up to set email alerts
|

The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
40
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 57 publications
(43 citation statements)
references
References 24 publications
3
40
0
Order By: Relevance
“…Although it is widely assumed that oral administration of 5-HTP results in increased synaptic release of 5-HT from cells in the raphe nuclei (Birdsall, 1998;Turner et al, 2006), empirical evidence to support this view is limited. In rats, relevant oral doses of 5-HTP (given without the coadministration of MAO inhibitors) result in increased 5-HTP and 5-HT immunoreactivity in the dorsal raphe nucleus, suggesting that 5-HTP is effectively transported across the blood-brain barrier and decarboxylated into 5-HT (Lynn-Bullock et al, 2004). Although several animal studies have demonstrated that 5-HTP administration can increase 5-HT levels in the central nervous system (reviewed in Lynn-Bullock et al, 2004), it remains unknown if these increases reflect functionally meaningful synaptic 5-HT release and stimulation of 5-HT activity over the long term (Meyers, 2000), or if enhancements in 5-HT release are unlikely due to regulation by autoreceptors (Suter and Collard, 1983).…”
Section: Introductionmentioning
confidence: 99%
“…Although it is widely assumed that oral administration of 5-HTP results in increased synaptic release of 5-HT from cells in the raphe nuclei (Birdsall, 1998;Turner et al, 2006), empirical evidence to support this view is limited. In rats, relevant oral doses of 5-HTP (given without the coadministration of MAO inhibitors) result in increased 5-HTP and 5-HT immunoreactivity in the dorsal raphe nucleus, suggesting that 5-HTP is effectively transported across the blood-brain barrier and decarboxylated into 5-HT (Lynn-Bullock et al, 2004). Although several animal studies have demonstrated that 5-HTP administration can increase 5-HT levels in the central nervous system (reviewed in Lynn-Bullock et al, 2004), it remains unknown if these increases reflect functionally meaningful synaptic 5-HT release and stimulation of 5-HT activity over the long term (Meyers, 2000), or if enhancements in 5-HT release are unlikely due to regulation by autoreceptors (Suter and Collard, 1983).…”
Section: Introductionmentioning
confidence: 99%
“…Portions of excreted urine were collected over 4 h. The increase in endogenous brain serotonin was produced by intraperitoneal injection of the rate-limiting precursor of serotonin biosynthesis, 5-HTP (Calbiochem, 5 mg/100 g body weight). We did not measure brain serotonin because it has been amply reported that a single intraperitoneal injection of 5-HTP to rats caused a fast and significant increase in the level of serotonin not only in plasma, but also in the brain because it rapidly passed through the blood brain barrier [22, 36, 37]. …”
Section: Methodsmentioning
confidence: 99%
“…Thus, it has been reported that serotonin may exert an inhibitory or virtually no in vivo or in vitro effect on AVP synthesis and secretion [11, 18, 19]. The experimental results reported for fluoxetine, a serotonin reuptake inhibitor, are also inconsistent [20,21,22]. Meanwhile there is ample evidence indicating that serotonin, its precursor, 5-hydroxytryptophan (5-HTP), and certain serotonin receptor agonists stimulate AVP release into peripheral blood [23,24,25,26,27].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In view of the rising popularity and wide availability of 5-HTP containing drinks, we feel that scientists and the general public alike would profit from an additional nugget of information regarding a previously unforeseen effect of 5-HTP consumption at an inappropriate time, as brought to light by recent literature in the area. 5-HTP crosses the blood -brain barrier upon systemic administration, bypasses the rate-limiting step in serotonin synthesis, elevates brain serotonin, 4 and affects non-REM sleep 5 in rodents, generally promoting wakefulness if administered at light onset, and promoting non-REM sleep with dark onset administration. In a recent study (March 2012), we investigated some of the effects 5-HTP had on the mammalian circadian system, using a nocturnal model.…”
mentioning
confidence: 99%